STIM Company Profile and Key Details

Neuronetics, Inc. (NASDAQ:STIM) closed at $1.46 USD, losing -$0.15 (-9.06%) from the previous close of $1.60. The stock is currently mid-range between its 52-week high and low $0.80 and $5.05. With a market capitalization of about $100.80 million, Neuronetics, Inc. is classified as a micro-cap and shows market-like volatility (beta ~0.94). Key stats such as the average daily volume over the past year has been around 2.03 million shares, volume is running light vs its 52-week average. Headquartered in Malvern, PA, Neuronetics, Inc. operates in the Healthcare sector and the Medical - Diagnostics & Research industry. Led by CEO Stephen J. Furlong, the company employs approximately 716 people and listed since June 28, 2018. Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally.

Short-term trend indicators are bullishly aligned (SMA20 -8.65%, SMA50 -14.77%, SMA200 -49.04%). The stock’s 14-day RSI is 44.26 (neutral), while the ATR of 0.18 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -76.01% below its high and over 18.14% above its low. Average 10-day trading volume of 3.72 million shares is significantly above the 3-month average of 1.94 million, indicating heightened recent market interest.

Neuronetics, Inc. generated EPS of -$0.82 over the past year. Five-year average earnings growth is 2.71%. Wall Street analysts project EPS growth of 37.99% annually over the next five years. The latest quarter delivered EPS of -$0.13. The next quarter is forecast at -$0.11. Next year's EPS is expected at $15.95. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 2 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $7.00 to $3.00. The high target offers 337.5% upside. The low target suggests 87.5% downside. The mean target is $5.00. This offers 212.5% upside. Neuronetics, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended November 04, 2025, missed forecasts by 11.98%. The prior quarter beat by 87.5%. Over the last six quarters, Apple has recorded several small beats. These include 21.17% in August 12, 2024.

Neuronetics, Inc. has 66.12 million shares outstanding. The public float is 40.97 million shares, elevated short interest at 13.25% of float. This equals 4.95 million shares. The short ratio is 3.86 days. Institutional investors hold 73.01% of the float. Insiders own 15.59%. Chernett Jorey holds 8.74 million shares, CANNELL CAPITAL LLC has 3.13 million shares and Sullivan Keith J has 1.52 million shares. Over the past six months, insider transactions show net selling. They sold 104.92 thousand shares across 7 transactions.

Neuronetics, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $10.27. This means the shares are trading below this model’s fair value.

Neuronetics, Inc. trades at a P/E ratio of -2.58, slightly below the S&P 500 average, with a price-to-sales ratio of 0.68 and a price-to-book ratio of 4.5 trading at moderately above to book value. The P/FCF stands at -4.79, also below market averages.

Our AI price prediction model suggests that Neuronetics, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -14.37%, with price expected at $1.37 by April 06, 2026, within a range of $1.16 to $1.58 3-Month Outlook: Projected fall of -44.38%, reaching $0.89 by June 19, 2026, with a range of $0.77 to $0.99. 1-Year Outlook: Projected loss of -55.62%, with price at $0.71 by March 23, 2027, within a range of $0.00 to $0.00.

Neuronetics, Inc. (NASDAQ:STIM) shares are up 40.22% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Neuronetics, Inc. trading at a premium to the broader market with a P/E of -2.58. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $7.33, suggesting 358.12% upside. Our AI forecast model points to short-term weakness (-14.37% over two weeks), a medium-term fall (-44.38% over three months), and a longer-term loss (-55.62% over one year), with expected trading ranges indicating moderate volatility.